Amgen BC’s scientists are at the forefront of research in immunology, biochemistry, cellular, molecular and structural biology, striving to discover pioneering medical treatments to support Amgen’s mission to serve patients. As one of the only global biopharmaceutical companies with a discovery research presence in Canada, Amgen BC’s research leverages new scientific breakthroughs for patient care, helping patients in their fight against cancer, osteoporosis, cardiovascular disease, and other serious illnesses.

Amgen’s Canadian research facility in Burnaby, British Columbia, plays an important role in contributing to the company’s legacy as a global leader in the discovery of early stage protein-based therapeutic candidates. Complementing our research capabilities, Amgen BC has invested heavily in expanding its on-site Data and Technology expertise, which has played a pivotal role in enhancing Amgen’s data analysis, digital technology and computational modelling capabilities across the Research and Development Spectrum.